phase I is continuing......direct quote from PR Released positive interim results from our human clinical trial of the Cell Pouch™ with insulin producing islets for the treatment of Type I diabetes, demonstrating biocompatibility and safety for up to 6 months, as well as proof of 30 day islet survival within the Cell Pouch™ following islet transplant. The clinical trial is ongoing.
Read more at https://www.stockhouse.com/news/press-releases/2014/06/03/sernova-provides-corporate-update-and-results-of-2014-annual-general-meeting#E0WZA5lYUbxtMVvC.99